Publication Beamlines Strategic Pillar
Stark, Alison; Filice, Fraser; Noël, James J.; Martin, Ronald R.; Sham, Tsun-Kong et al. (2021). Retrieving Tarnished Daguerreotype Content Using X-ray Fluorescence Imaging—Recent Observations on the Effect of Chemical and Electrochemical Cleaning Methods. Heritage 4(3) , 1605-1615. 10.3390/heritage4030089. CLS-APS
Wang, F.; Cheng, W.; Shang, H.; Wang, R.; Zhang, B. et al. (2021). The Crystal Structure of human MTH1 from Biortus. Protein Data Bank: 7esf. CMCF-ID
Allen, Meghan; Blyth, Rob; Cubbon, Grant; Ribeiro, Sandra; Weist, Erin et al. (2021). Operating the Canadian Light Source during the Pandemic: Safety, Innovations, and Perseverance. Synchrotron Radiation News 34(1-3) , 21-23. 10.1080/08940886.2021.1902720. SGM
Parashar, Abhinav; Gourgas, Ophélie; Lau, Kirk; Li, Jingjing; Muiznieks, Lisa et al. (2021). Elastin calcification in in vitro models and its prevention by MGP’s N-terminal peptide. Journal of Structural Biology 213(1) , 107637. 10.1016/j.jsb.2020.107637. SXRMB
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.